TY - JOUR
T1 - Efficacy of intraductal placement of nonflared fully-covered metal stent for refractory perihilar benign biliary strictures
T2 - A multicenter prospective study with long-term observation
AU - Matsumoto, Kazuyuki
AU - Kato, Hironari
AU - Fujii, Masakuni
AU - Ueki, Toru
AU - Saragai, Yosuke
AU - Tsugeno, Hirofumi
AU - Mannami, Tomohiko
AU - Okada, Hiroyuki
N1 - Publisher Copyright:
© 2022 Japanese Society of Hepato-Biliary-Pancreatic Surgery.
PY - 2022
Y1 - 2022
N2 - Background: Endoscopic fully-covered self-expandable metal stents (FCSEMSs) are used to treat benign biliary strictures (BBSs); however, treatment for perihilar BBSs is technically challenging. The aim of this study was to evaluate the usefulness of an unflared FCSEMS designed for intraductal placement in patients with refractory perihilar BBS. Methods: Twenty-two consecutive patients with perihilar BBS unresolved by endoscopic plastic stent placement at 13 tertiary medical centers were prospectively enrolled. The FCSEMS was placed above the papilla and removed after 4 months. The primary outcome was stricture resolution at 4 months, and the secondary outcomes were technical success, stent removal, adverse events, and recurrence. Results: The technical success rate of intraductal FCSEMS placement was 100%, and plastic stent placement at contralateral or side branch was performed in 86% of patients. The rate of successful stent removal at 4 months was 100%, and stricture resolution was observed in 91% of patients. Stent migration or stent-induced de novo stricture did not occur in any patient. The stricture recurrence rate was 16%, and the median (interquartile range) follow-up duration was 2.8 (1.6-3.3) years. Conclusions: Intraductal placement of unflared FCSEMS is effective treatment for refractory perihilar BBS.
AB - Background: Endoscopic fully-covered self-expandable metal stents (FCSEMSs) are used to treat benign biliary strictures (BBSs); however, treatment for perihilar BBSs is technically challenging. The aim of this study was to evaluate the usefulness of an unflared FCSEMS designed for intraductal placement in patients with refractory perihilar BBS. Methods: Twenty-two consecutive patients with perihilar BBS unresolved by endoscopic plastic stent placement at 13 tertiary medical centers were prospectively enrolled. The FCSEMS was placed above the papilla and removed after 4 months. The primary outcome was stricture resolution at 4 months, and the secondary outcomes were technical success, stent removal, adverse events, and recurrence. Results: The technical success rate of intraductal FCSEMS placement was 100%, and plastic stent placement at contralateral or side branch was performed in 86% of patients. The rate of successful stent removal at 4 months was 100%, and stricture resolution was observed in 91% of patients. Stent migration or stent-induced de novo stricture did not occur in any patient. The stricture recurrence rate was 16%, and the median (interquartile range) follow-up duration was 2.8 (1.6-3.3) years. Conclusions: Intraductal placement of unflared FCSEMS is effective treatment for refractory perihilar BBS.
KW - benign biliary stricture
KW - fully-covered self-expandable metal stent
KW - intraductal placement
KW - refractory biliary stricture
UR - http://www.scopus.com/inward/record.url?scp=85132172390&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85132172390&partnerID=8YFLogxK
U2 - 10.1002/jhbp.1188
DO - 10.1002/jhbp.1188
M3 - Article
C2 - 35657019
AN - SCOPUS:85132172390
SN - 1868-6974
JO - Journal of Hepato-Biliary-Pancreatic Sciences
JF - Journal of Hepato-Biliary-Pancreatic Sciences
ER -